← back to search

Julie Wang

Shanghai Jiao Tong University · CN
Area of research
Immunology and Allergy · Physiology
Research interest
Research interests include Food Allergy and Anaphylaxis Research, Allergic Rhinitis and Sensitization, Asthma and respiratory diseases, and Eosinophilic Esophagitis.
h-index
80
citations
24,668
works
759
NIH funding
primary concept
Medicine
email

Recent publications

Enhancing nasal retention: using the mucosal blanket to structure sprays
2026cited by 0position: contributordoi
Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT
Journal of Allergy and Clinical Immunology 2025cited by 6position: middledoi
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies
Journal of Allergy and Clinical Immunology 2025cited by 6position: middledoi
Optimizing Exosome Lipid Hybrid Nanoparticles for Enhanced siRNA Delivery and Improved Therapeutic Anticancer Efficacy In Vivo
ACS Nano 2025cited by 6position: middledoi
Brain distribution study of [14C]-Riluzole following intranasal administration in mice
International Journal of Pharmaceutics 2025cited by 2position: contributordoi
Omalizumab for the Treatment of Multiple Food Allergies
New England Journal of Medicine 2024cited by 289position: middledoi
Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
˜The œLancet. Gastroenterology & hepatology 2024cited by 235position: middledoi
Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent
Nature Nanotechnology 2024cited by 163position: middledoi
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology 2024cited by 130position: middledoi
Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent.
2024cited by 111position: contributordoi
The Natural History and Risk Factors for the Development of Food Allergies in Children and Adults
Current Allergy and Asthma Reports 2024cited by 54position: lastdoi
miRNA-148a–containing GMSC-derived EVs modulate Treg/Th17 balance via IKKB/NF-κB pathway and treat a rheumatoid arthritis model
JCI Insight 2024cited by 41position: middledoi
Preparing Patients for Oral Immunotherapy (PPOINT): International Delphi consensus for procedural preparation and consent
Journal of Allergy and Clinical Immunology 2024cited by 35position: middledoi
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy
Allergy 2024cited by 32position: middledoi
Identifying Children at Risk of Growth and Nutrient Deficiencies in the Food Allergy Clinic
The Journal of Allergy and Clinical Immunology In Practice 2024cited by 28position: middledoi
Graphene Oxide Nanosheets Toxicity in Mice Is Dependent on Protein Corona Composition and Host Immunity
ACS Nano 2024cited by 26position: middledoi
RNA lipid nanoparticles as efficient in vivo CRISPR-Cas9 gene editing tool for therapeutic target validation in glioblastoma cancer stem cells
Journal of Controlled Release 2024cited by 25position: middledoi
The use and implementation of omalizumab as food allergy treatment: Consensus-based guidance and Work Group Report of the Adverse Reactions to Foods Committee of the American Academy of Allergy, Asthma & Immunology
Journal of Allergy and Clinical Immunology 2024cited by 20position: middledoi
Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy
Journal of Controlled Release 2024cited by 19position: middledoi
Anaphylaxis: A 2023 practice parameter update
Annals of Allergy Asthma & Immunology 2023cited by 273position: middledoi
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials
Journal of Allergy and Clinical Immunology 2023cited by 141position: middledoi
Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy
New England Journal of Medicine 2023cited by 127position: middledoi
Intranasal administration of edaravone nanoparticles improves its stability and brain bioavailability
Journal of Controlled Release 2023cited by 50position: middledoi
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders
Journal of Allergy and Clinical Immunology 2023cited by 36position: middledoi
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach
Journal of Allergy and Clinical Immunology 2023cited by 19position: middledoi
Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery.
2023cited by 16position: contributordoi
The SunBEAm birth cohort: Protocol design
Journal of Allergy and Clinical Immunology Global 2023cited by 9position: middledoi
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NEJM Evidence 2022cited by 1,058position: middledoi
Drug allergy: A 2022 practice parameter update
Journal of Allergy and Clinical Immunology 2022cited by 490position: middledoi
Multiscale study of the oral and gut environments in children with high- and low-threshold peanut allergy
Journal of Allergy and Clinical Immunology 2022cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Khuloud T. Al‐Jamal · King's College London38 papers (2013–2025)Song Guo Zheng · Guangdong Medical College11 papers (2012–2024)Jane Sosabowski · Novartis (Switzerland)9 papers (2013–2019)Adam A. Walters · King's College London9 papers (2019–2025)Noelia Rubio · Universidad de Alcalá9 papers (2013–2016)Farid N. Faruqu · King's College London8 papers (2019–2024)Rebecca Klippstein · King's College London7 papers (2014–2019)Matthew Greenhawt · Texas Children's Hospital7 papers (2018–2024)Revadee Liam‐Or · King's College London6 papers (2020–2025) · 6 papers (2020–2026)Pedro M. Costa · King's College London6 papers (2015–2024)Houmam Kafa · Atomic Energy Commission of Syria5 papers (2013–2016)Marcus Shaker · Dartmouth College5 papers (2020–2024)Yue Qin · University of California, Los Angeles5 papers (2021–2025)Khuloud T. Al-Jamal · King's College - North Carolina5 papers (2019–2024)Alberto Bianco · Harbin Institute of Technology5 papers (2013–2019)Phil Lieberman · University of Southern California4 papers (2020–2023)David Brand · Memphis VA Medical Center4 papers (2012–2018)Lizhou Xu · Zhejiang University of Science and Technology4 papers (2019–2024)Maogen Chen · Sun Yat-sen University4 papers (2012–2012)